Core Laboratories FY 2025 net income fell 5.5% to USD 30 million

Reuters03-23
<a href="https://laohu8.com/S/CLB">Core Laboratories</a> FY 2025 net income fell 5.5% to USD 30 million
  • Core Lab published its annual report (Form 10-K), reporting revenue of USD 526.5 million and operating income of USD 56.5 million.
  • Net income was USD 30.4 million, while diluted earnings per share were USD 0.65.
  • Service revenue rose 2.9% to USD 399.4 million, driven by growth in both U.S. and international markets including increased demand for well completion diagnostic services and crude assay services.
  • Product sales fell 6.3% to USD 127.1 million, in line with a 6% decline in the U.S. land-based average rig count.
  • Cash provided by operating activities declined 34.3% to USD 37.0 million, which the company attributed primarily to higher working capital use, including accounts receivable increases and higher net cash used in unearned revenues.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Laboratories Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-118177), on March 23, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment